BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 1 hit Enz. Inhib. hit(s) with Target = 'Transient receptor potential cation channel subfamily V member 1' and Ligand = 'BDBM125066'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Transient receptor potential cation channel subfamily V member 1


(Homo sapiens (Human))
BDBM125066
PNG
(US8765733, 53)
Show SMILES CC1CCN(CC1)c1nc(ccc1CNC(=O)Nc1ccc(CNS(C)(=O)=O)c(C)c1)C(F)(F)F
Show InChI InChI=1S/C23H30F3N5O3S/c1-15-8-10-31(11-9-15)21-18(5-7-20(30-21)23(24,25)26)13-27-22(32)29-19-6-4-17(16(2)12-19)14-28-35(3,33)34/h4-7,12,15,28H,8-11,13-14H2,1-3H3,(H2,27,29,32)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
5n/an/an/an/an/an/an/an/a



Gruenenthal GmbH

US Patent


Assay Description
The FLIPR protocol consists of 2 substance additions. First the compounds to be tested (10 μM) are pipetted onto the cells and the Ca2+ influx i...


US Patent US8765733 (2014)


BindingDB Entry DOI: 10.7270/Q2BZ64QQ
More data for this
Ligand-Target Pair